openPR Logo
Press release

Anti-Viral Therapies and Current COVID-19 Impact Market Insight Report By Growth, segmentation, performance, Competitive Strategies Forecast with AbbVie; Abbott; Astrazeneca; F. Hoffmann-La Roche Ltd; Bristol-Myers Squibb Company;

09-24-2020 03:26 PM CET | Health & Medicine

Press release from: The Insight Partners

/ PR Agency: The Insight Partners
anti - viral therapies market

anti - viral therapies market

A report by The Insight Partner's on the Anti-Viral Therapies market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the market by monitoring the strengths and weaknesses of prominent contributors and their key products.

The anti - viral therapies market is expected to reach US$ 76,282.63 million by 2027 from US$ 40,589.79 million in 2019; the market is estimated to grow at a CAGR of 8.3% from 2020 to 2027.

Request for sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00012650/?openpr-10225

Company Profiles

AbbVie Inc.
Abbott
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Aurobindo Pharma
AstraZeneca

Market Insights

Rising Government Support for Research Activities and Clinical Trials

The clinical trials industry has seen exceptional growth in the last 10 years. In August 2019, the US Food and Drug Administration (USFDA) revealed that it awarded 12 new clinical trial research grants of more than US$ 15 million in total, for the period 2020–2023, to improve the development of medical products for patients with rare diseases. The grants were conferred to principal investigators from industry and academics across the country. The FDA awarded the grants through the Orphan Products Clinical Trials Grants Program, which is funded by Congress to promote the clinical development of medical foods, biologics, drugs, and medical devices for the treatment of rare diseases. The grants are intended to considerably contribute to the marketing approval of products to treat rare diseases and provide essential data for the development of such products. For clinical trials of possibly life-changing treatments for patients with rare diseases, the FDA has been offering much-needed financial support for more than 35 years. In addition, the Orphan Products Clinical Trials Grants Program’s contributions have supported research that will led to the marketing approval of treatments for rare diseases.

COVID-19 vaccine development has attained high pace due to large number of participants focusing on clinical trials and collaborations to make certain rapid growth and sufficient production capacity. In addition, the UK government has committed to provide US$ 99.9 million (£84 million) in funding and manufacturing support to researchers to work on this vaccine program. Further, the US government has agreed to fund US$ 483 million for Moderna Inc. to develop and test its COVID-19 vaccine, which is currently in an initial clinical trial. The biotech industry in Europe is playing a vital part in the fight against COVID-19, in terms of developing vaccines, therapeutic drugs, diagnostics, and research. For instance, the European Commission offered US$ 105.8 million (EUR 89 million) to CureVac for the development of COVID-19 vaccine, in March 2020.

Such significant funding initiatives by governments for encouraging research activities and clinical trials are boosting the growth of the anti-viral therapies market.

Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behavior & the growth of the market as well as industries.

Global Anti - Viral Therapies Market– By Type

• Generic Drugs
• Branded Drugs

Global Anti - Viral Therapies Market– By Mechanism of Action

• Nucleotide Polymerase Inhibitors
• Reverse Transcriptase Inhibitors
• Protease Inhibitors
• Others

Global Anti - Viral Therapies Market– By Application

• HIV
• Hepatitis
• Herpes
• Virus Influenza
• Other Applications

The COVID-19 outbreak is currently going the world over, the Anti-Viral Therapies Market report covers the impact of the corona-virus on top company’s growth. This research report categorizes as the key players in the Anti-Viral Therapies market and also gives a comprehensive study of Covid-19 impact analysis of the market by regions like (Americas, Europe APAC, and EMEA).

The report offers key drivers that propel the growth in the global Anti-Viral Therapies market. These insights help market players in devising strategies to gain market presence. The research also outlined the restraints of the market. Insights on opportunities are mentioned to assist market players in taking further steps by determining the potential in untapped regions.

This report focuses on the global Anti-Viral Therapies market with the future forecast, growth opportunity, key market, and key players. The study objectives are to present the Anti-Viral Therapies market development in North America, Europe, China, Japan, Southeast Asia, India, and Central & South America.

What’s included

Market Dynamics
Competitive Analysis
Market Trends And Market Outlook
Market Share And Market Size
Opportunities And Customer Analysis
Product Pricing Research

Purchase Copy of This Report at https://www.theinsightpartners.com/buy/TIPRE00012650/?openpr-10225

Contact us: –
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About us: –
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Viral Therapies and Current COVID-19 Impact Market Insight Report By Growth, segmentation, performance, Competitive Strategies Forecast with AbbVie; Abbott; Astrazeneca; F. Hoffmann-La Roche Ltd; Bristol-Myers Squibb Company; here

News-ID: 2141900 • Views: 369

More Releases from The Insight Partners

Women Intimate Care Market Segmentation, Main Players, Size, SWOT Analysis 2021 …
The proposed Women Intimate Care Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. The Women Intimate Care Market sample report includes an
Lacrimal Stent and Intubation Sets Market 2021 Revenue, Growth Rate, Application …
Lacrimal Stent and Intubation Sets Market study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. Lacrimal stents are small diameter tubes placed within the nasolacrimal system to maintain patency. In most cases, the tubes are typically composed of silicone or similar semi-rigid yet
3D Hip and Knee Implant Market Share, Trends and Growth 2021 to 2028
3D Hip and Knee Implant Market study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. 3D Implants is a layer-by-layer process to create physical objects out of digital 3D blueprints. A 3D implant involves knee realignment using additives manufacturing technology, improving the effectiveness
Self-Monitoring of Blood Glucose Market Technological Advancement and Growth Ana …
Self-Monitoring of Blood Glucose Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report. Request Exclusive Sample PDF of this Report @ https://www.theinsightpartners.com/sample/TIPRE00015252/?utm_source=OpenPR&utm_medium=10458 Our expert team is consistently working

All 5 Releases


More Releases for Therapies

Gene Therapies Global Market Research Report 2019
Gene Therapies Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/gene-therapies-market/80857 The report firstly introduced the Gene Therapies basics: definitions, classifications, applications and market
Lung Cancer and Therapies Meet 2019
Lexis is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products. It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques to treat Lung Cancer with different approach. This meet enlightens
Cellular Therapies 2018
Annual Congress on Cellular Therapies, Stem Cells and Bio Medical Engineering, October 17-18, 2018 New York, USA hosted by Conferences Series. Through the theme "Modern Research and Developments in Cellular Therapies, Stem Cells & Bio Medical Engineering", conference will explore the advances in Cell Therapy, Medical Approaches, Stem cells, Biomedical Engineering etc. This conference brings a novel and International mixture of giant and medium Cell therapeutics and Bio Medical Engineering,
Cellular Therapies 2018
It takes us immense pleasure to announce the conference that “Annual Congress on Cellular Therapies, Stem Cells and Bio Medical Engineering” which is going to be held during October 17-18, 2018 at New York, USA. Cellular Therapies 2018 conference will focus on the latest and exciting innovations in all areas of Cellular Therapies and Stem Cell Research, Biomedical Engineering, Medicine which offer a unique opportunity for investigators across the globe
B-Cell Maturation Antigen Targeted Therapies Market
Multiple myeloma is an incurable disease of plasma cells, which needs some intervention by clinical researchers. However, there have been recent success in developing such therapy that can be effective in hematologic malignancies such as chimeric antigen receptor CAR-T cell therapy, which is expected to be promising in cancer treatment. However, researchers have found little success in finding a specific target antigen under CAR T-cell therapies for treating multiple myeloma.
Antibacterial Therapies Drug Development Pipeline Review, 2017
ReportsWorldwide has announced the addition of a new report title Antibacterial Therapies Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports. Summary The antibacterial drug market covers the drugs used in the prophylaxis and treatment of bacterial infections. With a growing global concern over antimicrobial resistance and its progressive growth, there is a pronounced need for innovation within this market. There are over 1400 products in active